Table 4 |
||||
|
Post-treatment changes in CRP, ESR, and Igs |
||||
| Post-treatment change from baseline (mean ± standard deviation) |
||||
|
|
||||
| Parameters |
6 weeks |
10 weeks |
18 weeks |
32 weeks |
|
|
||||
| n = 13 |
n = 13 |
n = 12 |
n = 10 |
|
| CRP |
0.42 ± 1.39 |
-0.02 ± 0.33 |
0.19 ± 0.60 |
0.03 ± 0.22 |
| ESR |
1.3 ± 15.0 |
1.5 ± 11.0 |
-0.9 ± 7.7 |
-0.3 ± 11.6 |
| n = 15 |
n = 13 |
n = 13 |
n = 9 |
|
| IgG |
29.7 ± 249.6 |
-31 ± 379.6 |
7.1 ± 313.5 |
-120.8 ± 363.3 |
| IgA |
1.1 ± 24.4 |
7.8 ± 46.9 |
-1.2 ± 59 |
-3.8 ± 62.4 |
| IgM |
-14.9 ± 25.3 |
-9.6 ± 28.3 |
-15.0 ± 32.8 |
-2.3 ± 34.8 |
|
|
||||
|
None of the changes from baseline in the above parameters was statistically significant. CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Ig, immunoglobulin. |
||||
|
Steinfeld et al. Arthritis Research & Therapy 2006 8:R129 doi:10.1186/ar2018 |
||||
